CD276 and neoplasm: B7-H3 is highly expressed across various malignancies, including NSCLC, CRC, cutaneous squamous cell cancer, pancreatic cancer, and breast cancer, where it promotes tumor proliferation, metastasis, and treatment resistance [110, 111].